1 study found for:    22432104 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed GLP-1 Agonist AVE0010 in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation in Monotherapy
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: lixisenatide (AVE0010);   Drug: placebo;   Device: insulin auto-injector

Indicates status has not been verified in more than two years